Skip to main content

Caliway Biopharmaceuticals

Caliway Biopharmaceuticals Co., Ltd. is a clinical-stage biopharmaceutical development enterprise based in Taiwan focused on medical aesthetics and inflammatory diseases. The company engages in the research and drug development of small-molecule therapeutics targeting subcutaneous fat reduction, scar prevention, and inflammatory skin conditions. Primary revenue model is focused on long-term drug development milestones, global technology licensing agreements, and eventual commercial sales of proprietary pharmaceutical formulations. Caliway Biopharmaceuticals targets healthcare providers, aesthetic medicine specialists, plastic surgery clinics, and dermatology practices in international markets. The enterprise operates as an emerging developer of novel aesthetic and therapeutic drug candidates within the Asian biopharmaceutical sector. Caliway Biopharmaceuticals Co., Ltd. is headquartered in New Taipei City, Taiwan, and its common shares are listed on the Taiwan Stock Exchange.

11 of the funds FundTelligence covers report a position in Caliway Biopharmaceuticals.

Legal name
Caliway Biopharmaceuticals Co. Ltd.
Sector
Health Care
Country
Taiwan
Funds holding it
11

Funds holding Caliway Biopharmaceuticals

Showing the 8 largest of 11 funds holding it.

Loading...